| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | FH535 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.002 |
| mRNA | BMS-270394 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.002 |
| mRNA | PFI-1 | GDSC1000 | pan-cancer | AAC | 0.1 | 0.002 |
| mRNA | Vorinostat | FIMM | pan-cancer | AAC | 0.45 | 0.002 |
| mRNA | navitoclax:birinapant (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.11 | 0.003 |
| mRNA | AZD7762 | CTRPv2 | pan-cancer | AAC | -0.095 | 0.004 |
| mRNA | tigecycline | CTRPv2 | pan-cancer | AAC | -0.14 | 0.005 |
| mRNA | WAY-362450 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.005 |
| mRNA | Teniposide | CTRPv2 | pan-cancer | AAC | -0.11 | 0.006 |
| mRNA | lapatinib | FIMM | pan-cancer | AAC | 0.42 | 0.006 |